Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis

Xin Li, Hao Liu, Ling Qin, Joseph Tamasi, Marika Bergenstock, Sue Shapses, Jean H M Feyen, Daniel A. Notterman, Nicola C. Partridge

Research output: Contribution to journalArticle

Abstract

Parathyroid hormone (PTH) stimulates bone formation when injected daily but causes severe bone loss with continuous infusion. The mechanism of its paradoxical effects is still elusive. In this study, we compared changes in the gene expression profile in bone induced by intermittent or continuous treatment with three different PTH peptides, PTH-(1-34), -(1-31), and -(3-34), in Sprague-Dawley female rats. PTH-(1-34) regulated numerous genes (∼1,000), but differentially, in both regimes. PTH-(1-31) regulated a similar number of genes in the intermittent regimen but fewer in the continuous regimen, consistent with its less potent catabolic effect. PTH-(3-34) regulated very few genes in both regimes, which suggests the protein kinase C pathway plays a limited role in mediating the dual effects of PTH, whereas the cAMP-dependent protein kinase A pathway appears to predominate. In the intermittent treatment, many genes encoding signaling mediators, transcription factors, cytokines, and proteases/protease inhibitors are regulated rapidly and cyclically with each PTH injection; genes associated with skeletal development show a slowly accruing pattern of expression. With continuous treatment, some genes are regulated from 6 h, and the mRNA levels are sustained with a longer infusion, whereas others show a kinetic decrease and then increase later. Significant up-regulation of genes stimulating osteoclastogenesis in the anabolic regime suggests a provocative and paradoxical theme for the anabolic effect of PTH that a full anabolic response requires a transient up-regulation of genes classically associated with a resorptive response. Ingenuity pathway analysis was performed on the microarray data. A novel signaling network was established that is differentially regulated in the two PTH treatment regimes. Key regulators are suggested to be AREG, CCL2, WNT4, and cAMP-responsive element modulator.

Original languageEnglish (US)
Pages (from-to)33086-33097
Number of pages12
JournalJournal of Biological Chemistry
Volume282
Issue number45
DOIs
StatePublished - Nov 9 2007

Fingerprint

Microarray Analysis
Microarrays
Electric network analysis
Parathyroid Hormone
Gene expression
Genes
Gene Expression
Bone
Cyclic AMP-Dependent Protein Kinases
Cyclic AMP Response Element Modulator
Osteogenesis
Up-Regulation
Anabolic Agents
Gene encoding
Bone and Bones
Protease Inhibitors
Protein Kinase C
Therapeutics
Rats
Transcriptome

ASJC Scopus subject areas

  • Biochemistry

Cite this

Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis. / Li, Xin; Liu, Hao; Qin, Ling; Tamasi, Joseph; Bergenstock, Marika; Shapses, Sue; Feyen, Jean H M; Notterman, Daniel A.; Partridge, Nicola C.

In: Journal of Biological Chemistry, Vol. 282, No. 45, 09.11.2007, p. 33086-33097.

Research output: Contribution to journalArticle

Li, Xin ; Liu, Hao ; Qin, Ling ; Tamasi, Joseph ; Bergenstock, Marika ; Shapses, Sue ; Feyen, Jean H M ; Notterman, Daniel A. ; Partridge, Nicola C. / Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis. In: Journal of Biological Chemistry. 2007 ; Vol. 282, No. 45. pp. 33086-33097.
@article{05719aa09b1a4a038329bdbbe36d7de1,
title = "Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis",
abstract = "Parathyroid hormone (PTH) stimulates bone formation when injected daily but causes severe bone loss with continuous infusion. The mechanism of its paradoxical effects is still elusive. In this study, we compared changes in the gene expression profile in bone induced by intermittent or continuous treatment with three different PTH peptides, PTH-(1-34), -(1-31), and -(3-34), in Sprague-Dawley female rats. PTH-(1-34) regulated numerous genes (∼1,000), but differentially, in both regimes. PTH-(1-31) regulated a similar number of genes in the intermittent regimen but fewer in the continuous regimen, consistent with its less potent catabolic effect. PTH-(3-34) regulated very few genes in both regimes, which suggests the protein kinase C pathway plays a limited role in mediating the dual effects of PTH, whereas the cAMP-dependent protein kinase A pathway appears to predominate. In the intermittent treatment, many genes encoding signaling mediators, transcription factors, cytokines, and proteases/protease inhibitors are regulated rapidly and cyclically with each PTH injection; genes associated with skeletal development show a slowly accruing pattern of expression. With continuous treatment, some genes are regulated from 6 h, and the mRNA levels are sustained with a longer infusion, whereas others show a kinetic decrease and then increase later. Significant up-regulation of genes stimulating osteoclastogenesis in the anabolic regime suggests a provocative and paradoxical theme for the anabolic effect of PTH that a full anabolic response requires a transient up-regulation of genes classically associated with a resorptive response. Ingenuity pathway analysis was performed on the microarray data. A novel signaling network was established that is differentially regulated in the two PTH treatment regimes. Key regulators are suggested to be AREG, CCL2, WNT4, and cAMP-responsive element modulator.",
author = "Xin Li and Hao Liu and Ling Qin and Joseph Tamasi and Marika Bergenstock and Sue Shapses and Feyen, {Jean H M} and Notterman, {Daniel A.} and Partridge, {Nicola C.}",
year = "2007",
month = "11",
day = "9",
doi = "10.1074/jbc.M705194200",
language = "English (US)",
volume = "282",
pages = "33086--33097",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "45",

}

TY - JOUR

T1 - Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis

AU - Li, Xin

AU - Liu, Hao

AU - Qin, Ling

AU - Tamasi, Joseph

AU - Bergenstock, Marika

AU - Shapses, Sue

AU - Feyen, Jean H M

AU - Notterman, Daniel A.

AU - Partridge, Nicola C.

PY - 2007/11/9

Y1 - 2007/11/9

N2 - Parathyroid hormone (PTH) stimulates bone formation when injected daily but causes severe bone loss with continuous infusion. The mechanism of its paradoxical effects is still elusive. In this study, we compared changes in the gene expression profile in bone induced by intermittent or continuous treatment with three different PTH peptides, PTH-(1-34), -(1-31), and -(3-34), in Sprague-Dawley female rats. PTH-(1-34) regulated numerous genes (∼1,000), but differentially, in both regimes. PTH-(1-31) regulated a similar number of genes in the intermittent regimen but fewer in the continuous regimen, consistent with its less potent catabolic effect. PTH-(3-34) regulated very few genes in both regimes, which suggests the protein kinase C pathway plays a limited role in mediating the dual effects of PTH, whereas the cAMP-dependent protein kinase A pathway appears to predominate. In the intermittent treatment, many genes encoding signaling mediators, transcription factors, cytokines, and proteases/protease inhibitors are regulated rapidly and cyclically with each PTH injection; genes associated with skeletal development show a slowly accruing pattern of expression. With continuous treatment, some genes are regulated from 6 h, and the mRNA levels are sustained with a longer infusion, whereas others show a kinetic decrease and then increase later. Significant up-regulation of genes stimulating osteoclastogenesis in the anabolic regime suggests a provocative and paradoxical theme for the anabolic effect of PTH that a full anabolic response requires a transient up-regulation of genes classically associated with a resorptive response. Ingenuity pathway analysis was performed on the microarray data. A novel signaling network was established that is differentially regulated in the two PTH treatment regimes. Key regulators are suggested to be AREG, CCL2, WNT4, and cAMP-responsive element modulator.

AB - Parathyroid hormone (PTH) stimulates bone formation when injected daily but causes severe bone loss with continuous infusion. The mechanism of its paradoxical effects is still elusive. In this study, we compared changes in the gene expression profile in bone induced by intermittent or continuous treatment with three different PTH peptides, PTH-(1-34), -(1-31), and -(3-34), in Sprague-Dawley female rats. PTH-(1-34) regulated numerous genes (∼1,000), but differentially, in both regimes. PTH-(1-31) regulated a similar number of genes in the intermittent regimen but fewer in the continuous regimen, consistent with its less potent catabolic effect. PTH-(3-34) regulated very few genes in both regimes, which suggests the protein kinase C pathway plays a limited role in mediating the dual effects of PTH, whereas the cAMP-dependent protein kinase A pathway appears to predominate. In the intermittent treatment, many genes encoding signaling mediators, transcription factors, cytokines, and proteases/protease inhibitors are regulated rapidly and cyclically with each PTH injection; genes associated with skeletal development show a slowly accruing pattern of expression. With continuous treatment, some genes are regulated from 6 h, and the mRNA levels are sustained with a longer infusion, whereas others show a kinetic decrease and then increase later. Significant up-regulation of genes stimulating osteoclastogenesis in the anabolic regime suggests a provocative and paradoxical theme for the anabolic effect of PTH that a full anabolic response requires a transient up-regulation of genes classically associated with a resorptive response. Ingenuity pathway analysis was performed on the microarray data. A novel signaling network was established that is differentially regulated in the two PTH treatment regimes. Key regulators are suggested to be AREG, CCL2, WNT4, and cAMP-responsive element modulator.

UR - http://www.scopus.com/inward/record.url?scp=36348946768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36348946768&partnerID=8YFLogxK

U2 - 10.1074/jbc.M705194200

DO - 10.1074/jbc.M705194200

M3 - Article

C2 - 17690103

AN - SCOPUS:36348946768

VL - 282

SP - 33086

EP - 33097

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 45

ER -